Mintz represented Granata Bio Corporation (Granata Bio), a biopharma company focused on invigorating the $3.6B global infertility medication market, in its $15M Series A+ funding round.
The funding round will support Granata Bio's efforts to explore new innovative assets in reproductive health and further strengthen its position as a leader within the reproductive health space.
The Mintz team was led by Tom Burton and Sarah Palmer, with support from Lorena Niebla, Elana Lerner Brockmann, and Becca Horton.
More information is available here.
Supporting Professionals
